First Light Asset Management, LLC Ligand Pharmaceuticals Inc Transaction History

First Light Asset Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$89.56 - $126.72 $4.05 Million - $5.73 Million	-45,192 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $22,737 - $41,175	333 Added 0.74%	45,192 $5.06 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $87,197 - $148,442	1,376 Added 3.16%	44,859 $3.26 Million
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $590,849 - $692,331	-6,095 Reduced 12.29%	43,483 $4.54 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $4.23 Million - $5.9 Million	-49,071 Reduced 49.74%	49,578 $4.94 Million
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $3.53 Million - $4.26 Million	-32,910 Reduced 25.02%	98,649 $11.3 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $3.94 Million - $5.3 Million	37,177 Added 39.39%	131,559 $16.5 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $2.74 Million - $5.81 Million	21,362 Added 29.25%	94,382 $12.8 Million
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $10.4 Million - $13.6 Million	-49,443 Reduced 40.37%	73,020 $20 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $852,604 - $1.18 Million	5,655 Added 4.84%	122,463 $25.4 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $670,553 - $883,332	4,837 Added 4.32%	116,808 $19.3 Million
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $6.24 Million - $7.15 Million	48,625 Added 76.76%	111,971 $15.3 Million
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $87,417 - $99,730	723 Added 1.15%	63,346 $8.63 Million
Q2 2017 Aug 14, 2017	BUY	N/A	62,623	62,623 $7.6 Million

277

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.82B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.